Insulet
PODD
#1123
Rank
NZ$34.40 B
Marketcap
NZ$488.72
Share price
-2.08%
Change (1 day)
4.80%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): NZ$6.10

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$5.99. In 2024 the company made an earnings per share (EPS) of NZ$10.24 an increase over its 2023 EPS that were of NZ$5.05.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.10-40.41%
2024NZ$10.24102.71%
2023NZ$5.054114.29%
2022NZ$0.12-69.57%
2021NZ$0.39109.09%
2020NZ$0.19-38.89%
2019NZ$0.31200%
2018NZ$0.10-113.04%
2017NZ-$0.79-9.8%
2016NZ-$0.87-60.47%
2015NZ-$2.2138.71%
2014NZ-$1.5912.05%
2013NZ-$1.42-23.15%
2012NZ-$1.85-12.2%
2011NZ-$2.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ICU Medical
ICUI
NZ-$0.53-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.22-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$3.17-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.87 198.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.79 130.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.35 6.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$35.12 486.24%๐Ÿ‡บ๐Ÿ‡ธ USA